Ritter Pharmaceuticals starts second phase of lactose intolerance trials
Ritter Pharmaceuticals has announced the dosing of the first patient in its Phase 2b/3 clinical trial of RP-G28 for the treatment of lactose intolerance.
Ritter Pharmaceuticals has announced the dosing of the first patient in its Phase 2b/3 clinical trial of RP-G28 for the treatment of lactose intolerance.
Iowa-based Country View Dairy is in talks to co-pack for another yogurt manufacturer in the near future to increase its own yogurt production, according to the company’s director of marketing and sales, Bob Howard.
Pulmuone Foods has announced its agreement to purchase substantially all of the assets of Vitasoy USA.